CRIS
Price
$3.46
Change
-$0.27 (-7.24%)
Updated
Jan 8 closing price
Capitalization
29.3M
INKT
Price
$0.78
Change
-$0.14 (-15.22%)
Updated
Jan 8 closing price
Capitalization
30.91M
69 days until earnings call
Ad is loading...

CRIS vs INKT

Header iconCRIS vs INKT Comparison
Open Charts CRIS vs INKTBanner chart's image
Curis
Price$3.46
Change-$0.27 (-7.24%)
Volume$72.29K
Capitalization29.3M
MiNK Therapeutics
Price$0.78
Change-$0.14 (-15.22%)
Volume$250.45K
Capitalization30.91M
CRIS vs INKT Comparison Chart
Loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRIS vs. INKT commentary
Jan 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Hold and INKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 10, 2025
Stock price -- (CRIS: $3.46 vs. INKT: $0.78)
Brand notoriety: CRIS and INKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 46% vs. INKT: 221%
Market capitalization -- CRIS: $29.3M vs. INKT: $30.91M
CRIS [@Biotechnology] is valued at $29.3M. INKT’s [@Biotechnology] market capitalization is $30.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $371.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileINKT’s FA Score has 0 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • INKT’s FA Score: 0 green, 5 red.
According to our system of comparison, INKT is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 5 TA indicator(s) are bullish while INKT’s TA Score has 5 bullish TA indicator(s).

  • CRIS’s TA Score: 5 bullish, 4 bearish.
  • INKT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRIS is a better buy in the short-term than INKT.

Price Growth

CRIS (@Biotechnology) experienced а +13.07% price change this week, while INKT (@Biotechnology) price change was +11.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.98%. For the same industry, the average monthly price growth was -2.85%, and the average quarterly price growth was +0.53%.

Reported Earning Dates

CRIS is expected to report earnings on Nov 02, 2023.

INKT is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+2.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INKT($30.9M) has a higher market cap than CRIS($29.3M). CRIS YTD gains are higher at: 13.072 vs. INKT (11.924). INKT has higher annual earnings (EBITDA): -14.07M vs. CRIS (-44.56M). CRIS has more cash in the bank: 20.9M vs. INKT (6.33M). CRIS has less debt than INKT: CRIS (3.26M) vs INKT (4.61M). CRIS has higher revenues than INKT: CRIS (10.3M) vs INKT (0).
CRISINKTCRIS / INKT
Capitalization29.3M30.9M95%
EBITDA-44.56M-14.07M317%
Gain YTD13.07211.924110%
P/E RatioN/AN/A-
Revenue10.3M0-
Total Cash20.9M6.33M330%
Total Debt3.26M4.61M71%
FUNDAMENTALS RATINGS
CRIS: Fundamental Ratings
CRIS
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRISINKT
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 18 days ago
75%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FICO1964.4229.26
+1.51%
Fair Isaac Corp
AOSL38.860.28
+0.74%
Alpha and Omega Semiconductor Limited
AMPY6.25-0.01
-0.16%
Amplify Energy Corp
LNTH94.00-2.92
-3.01%
Lantheus Holdings
USEG1.82-0.06
-3.19%
US Energy Corp

CRIS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRIS has been loosely correlated with INKT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CRIS jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRIS
1D Price
Change %
CRIS100%
-7.24%
INKT - CRIS
39%
Loosely correlated
-15.22%
ORMP - CRIS
34%
Loosely correlated
-1.65%
UBX - CRIS
31%
Poorly correlated
-26.52%
GOSS - CRIS
31%
Poorly correlated
-5.41%
ALNY - CRIS
31%
Poorly correlated
+1.95%
More

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-15.22%
RAIN - INKT
43%
Loosely correlated
-5.81%
CRIS - INKT
41%
Loosely correlated
-7.24%
CADL - INKT
36%
Loosely correlated
+4.55%
ABCZF - INKT
33%
Loosely correlated
N/A
TERN - INKT
30%
Poorly correlated
-6.84%
More